Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Drug-Delivery Platform Could Help Smokers Stub Cigarettes
Lexaria recently announced its entry into a partnership with a tobacco giant to fund the research and development of oral nicotine delivery solutions The company received a cannabis R&D license from Health Canada LXRP also announced its receipt of four new patents and its launch of ChrgD+ Many consumers don’t realize that they don’t need to smoke to partake of nicotine. In fact, new advancements are providing an alternative to the risks associated with smoking, which were first officially revealed by a damning surgeon general report in 1963 linking smoking to lung cancer, emphysema and heart disease. Case in point,…